|
Financial Snapshot For September 2010
|
|
|
|
|
Biotech Sector Breaks Its Own Record
|
|
|
|
|
| A rotating collection of articles from Signals’ archives on selected topics of interest. |
|
|
A handy guide that tracks recent name changes in the biotech sector. |
|
Signals Magazine
is published by
Recap
|
|
| Steady As She Goes
Biotech and specialty pharma firms raised nearly $14 billion in the first half of 2010 – and if the pace continues for the rest of the year, it could be a record-breaker. |
|
| Biotech Drug Approvals: A Year Of Firsts
The FDA approved more new biotech and biotech-related therapies in 2009 than it had since at least 2000 – and many of them address previously untreatable diseases. |
|
| Flu Fighters
We have never been more prepared to take on the flu than we are now – but will the new vaccines and drugs be enough to forestall a virulent pandemic? |
|
|